February 22, 2024
RegMed Investors (RMi) Closing Bell: will the “elevation” trend stay a friend?
February 21, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy equities closes barely positive
February 20, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy equities falter, led by Nasdaq
February 16, 2024
RegMed Investors (RMi) Closing Bell: the cell and gene therapy closed barely positive after a bumpy session
February 15, 2024
RegMed Investors (RMi) Closing Bell: riding the bull
February 14, 2024
RegMed Investors (RMi) Closing Bell: yippee-kai-yay
February 13, 2024
RegMed Investors (RMi) Closing Bell: CPI infused dominoes topple the cell and gene therapy sector
February 12, 2024
RegMed Investors (RMi) Closing Bell: testing, testing, testing the flight plan request
February 9, 2024
RegMed Investors (RMi) Closing Bell: hang-on to reward prospects for a while
February 8, 2024
RegMed Investors (RMi) Closing Bell: share prices rides on the sector’s merry-go-round
February 7, 2024
RegMed Investors (RMi) Closing Bell: The RegMed sector was stuck with sentiment diarrhea
February 6, 2024
RegMed Investors (RMi) Closing Bell: electronic trader were not conflicted, saw the decline, popped the cork to carbonate some fizz in the sector
February 5, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector passes more gas
February 2, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector fluctuates what’s different?
February 1, 2024
RegMed Investors (RMi) Closing Bell: back on the roller-coaster
January 31, 2024
RegMed Investors (RMi) Closing Bell: When you are a cell and gene therapy believer, the benefit of the doubt is immeasurable – the sector is oversold
January 30, 2024
RegMed Investors (RMi) Closing Bell: What a tangled sector we invest, the cell and gene therapy universe
January 29, 2024
RegMed Investors (RMi) Closing Bell: volatility varies the share pricing risks to share pricing
January 26, 2024
RegMed Investors (RMi) Closing Bell: strapped-in for a rough ride
January 25, 2024
RegMed Investors (RMi) Closing Bell: the tug-of-war got tugged over the line
January 24, 2024
RegMed Investors (RMi) Closing Bell: Occam’s Razor
January 22, 2024
RegMed Investors (RMi) Closing Bell: got some
January 20, 2024
RegMed Investors (RMi) Closing Bell: glad the week is over; we need to review the oversold
January 18, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector loses muscle strength while clinging to newest bottoms
January 17, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector clings to newest bottoms
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors